Clinical Trials Browser

Terminated × pomalidomide × Lymphoid × Clear all

Waldenstrom Macroglobulinemia

NCT04305444 2025-01-08

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Leukemia, Lymphatic Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT01078974 2016-07-25

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Phase 1 Terminated

7 enrolled 8 charts

Lymphoid

Waldenstrom Macroglobulinemia

Clinical Trials

Pomalidomide in Treating Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia

Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia